Θεραπείες - Ενδείξεις

Brief Description of Vascular Diseases

Vascular diseases encompass a wide range of conditions that affect blood circulation both in the major blood vessels and in the delicate network of the microcirculation.

From diabetic foot and chronic venous ulcers to limb ischemia and tissue necrosis, these are conditions that often progress silently and can lead to serious complications if they are not treated promptly and comprehensively.

The common denominator in most vascular diseases is inadequate tissue oxygenation, either due to narrowing or obstruction of blood vessels or due to dysfunction of the microcirculation.

This very deficiency is the primary target of treatment in a hyperbaric oxygen chamber: by functioning as a complement to conventional vascular treatment, it restores oxygenation even where blood supply is severely compromised.

Key Characteristics of the Treatment

Under hyperbaric conditions, oxygen dissolves in large quantities directly into the blood plasma, independently of hemoglobin and narrowed blood vessels.

This means that it can reach tissues that normally lack adequate blood supply, essentially “bypassing” the vascular damage to nourish the cells in need.

In the vascular field, hyperbaric oxygen chamber therapy stands out for four key properties: its ability to induce neoangiogenesis through VEGF, meaning the formation of new blood vessels in ischemic areas; its anti-inflammatory action, which breaks the vicious cycle of ischemia and inflammation; its bactericidal action against anaerobic pathogens that thrive in the hypoxic environment of chronic wounds; and the activation of healing cells, such as fibroblasts and keratinocytes, which are impaired under hypoxic conditions.

Scientific Clinical Trials & Community

The vascular indications for hyperbaric oxygen are among the most extensively documented applications of the method. The Undersea and Hyperbaric Medical Society (UHMS) and the European Committee for Hyperbaric Medicine (ECHM) have included conditions such as diabetic foot, necrotizing fasciitis, gas gangrene, and chronic ischemic wounds among the approved indications with a high level of scientific evidence.

Randomized clinical trials and meta-analyses have demonstrated reductions in amputation rates in diabetic foot patients, accelerated healing of chronic ulcers, and improved microcirculation in patients who received hyperbaric oxygen as a complement to conventional treatment.

The scientific community consistently recognizes that the best outcomes are achieved when the method is applied as part of a comprehensive treatment plan rather than as a standalone intervention.

Purpose of Sports Medicine

Sports medicine focuses on the prevention, diagnosis, and treatment of injuries and conditions related to physical activity, both in professional athletes and in amateurs or individuals who exercise as part of their daily lives.

From acute injuries that occur during competition to chronic conditions that develop gradually as a result of repetitive strain, the spectrum of sports-related pathology is extremely broad.

Hyperbaric oxygen chamber therapy is an evidence-based complementary option in sports medicine, aiming to accelerate recovery, reduce time away from activity, and support the body's natural regenerative capacity.

It does not replace conventional medical treatment; rather, it serves as a powerful complementary method that enhances its effectiveness.

Hyperbaric Oxygen Chamber Therapy

Within the field of sports medicine, hyperbaric oxygen chamber therapy stands out for three primary properties: its anti-inflammatory action, its support of tissue regeneration, and its effects on muscle recovery.

Under increased atmospheric pressure, oxygen dissolves in large quantities in the plasma and reaches tissues with reduced blood flow, precisely where healing requires the greatest support.

In addition, it activates mechanisms of neoangiogenesis, stimulates collagen synthesis, and reduces post-traumatic edema, factors that are crucial to the quality and speed of recovery. Its non-invasive nature and lack of significant side effects make it a particularly attractive option in the sports setting.

Research and the Scientific Community

The use of hyperbaric oxygen in sports medicine is supported by a growing number of clinical studies and reports from professional sports teams internationally.

Research involving athletes with acute soft-tissue injuries, muscle strains, tendinopathies, and postoperative rehabilitation has demonstrated shorter recovery times, reduced pain, and earlier functional return compared with corresponding groups that did not receive hyperbaric oxygen.

In several professional football, basketball, and contact-sport teams, hyperbaric oxygen has been incorporated into rehabilitation protocols for injured athletes.

The international scientific community is increasingly recognizing its role, while emphasizing the importance of individualized application and its use as a complementary treatment.

General Information on Aesthetics & Wellness

The modern concept of health and wellness is not limited to the absence of disease; it extends to maintaining biological youthfulness, improving appearance, and enhancing overall vitality.

Within this context, hyperbaric oxygen chamber therapy emerges as a scientifically supported option that acts on the root of many aesthetic and functional changes associated with aging or everyday strain: the gradual decline in cellular oxygenation.

Over the years, the microcirculation of the skin and superficial tissues deteriorates, collagen production decreases, cellular metabolism slows down, and the tissues’ ability to self-renew becomes weaker.

Hyperbaric oxygen chamber therapy does not reverse the passage of time, but it provides cells with the biological conditions they need to function better, regenerate more effectively, and preserve their structural and functional characteristics for longer.

Key Characteristics of the Treatment

In the field of aesthetics and wellness, hyperbaric oxygen chamber therapy differs substantially from conventional aesthetic treatments: it does not act superficially on the skin, but rather improves the underlying biological processes that determine its structure, elasticity, and radiance.

Tissue hyperoxygenation under increased pressure activates fibroblasts to increase collagen and elastin synthesis, improves cellular energy production through enhanced mitochondrial function, stimulates neoangiogenesis that improves skin microcirculation, and activates antioxidant systems that combat free-radical damage.

The result of these mechanisms is an improvement in skin texture and tone, a reduction in visible signs of aging, faster healing following aesthetic procedures, and an overall sense of vitality that reflects improved cellular function.

Scientific Basis for the Application of Hyperbaric Oxygen

Applications of hyperbaric oxygen in aesthetics and wellness are based on well-established biological mechanisms that have been extensively studied in the medical field.

VEGF-mediated neoangiogenesis, activation of collagen synthesis, improved mitochondrial function, and antioxidant activity are mechanisms supported by numerous clinical studies in medical indications, and their application in the aesthetic field is beginning to be supported by a growing body of research.

Studies involving patients who underwent courses of hyperbaric oxygen therapy have documented objectively measurable improvements in skin health parameters—hydration, elasticity, and skin thickness—as well as increases in collagen markers.

The scientific community recognizes the growing interest in this field, while emphasizing the importance of individualized application and its complementary, rather than exclusive, use.

What Are Autoimmune Diseases?

Autoimmune diseases constitute a heterogeneous group of chronic conditions in which the immune system attacks healthy tissues and organs of the body itself.

Despite the diversity of their clinical manifestations—from the joints affected by rheumatoid arthritis to the nerves affected by multiple sclerosis and the blood vessels affected by vasculitis—they share a common biological basis: pathological immune activation, chronic inflammation, and oxidative stress that damage target tissues.

Hyperbaric oxygen chamber therapy does not replace immunomodulatory or biologic treatment, which remains the cornerstone of managing autoimmune diseases.

It functions as a complementary intervention that addresses the biological consequences of chronic autoimmune inflammation: it improves the oxygenation of tissues that have suffered ischemic damage, reduces chronic inflammation, and restores impaired functions, thereby substantially improving the patient's quality of life.

What Are the Key Characteristics of the Treatment?

In autoimmune diseases, hyperbaric oxygen chamber therapy primarily utilizes four properties. First, it exerts an immunomodulatory effect: it inhibits the Th17/IL-17 axis involved in many autoimmune inflammatory processes, while enhancing regulatory T cells (Tregs), which help control autoimmunity.

Second, it systematically reduces inflammatory cytokines (TNF-α, IL-1β, IL-6), which are key mediators of tissue damage. Third, it improves the oxygenation of tissues affected by vascular damage caused by chronic inflammation. Fourth, it activates antioxidant systems that counteract the oxidative stress associated with autoimmune diseases.

These effects are not localized to a single organ; they act systemically, making the method potentially applicable to conditions with multisystem manifestations.

Scientific Evidence

The scientific evidence for the use of hyperbaric oxygen in autoimmune diseases is at different stages of maturity depending on the condition.

For multiple sclerosis and Crohn’s disease, there are clinical studies with evaluated outcomes. For other indications, such as rheumatoid arthritis, lupus, and vasculitis, the available data come from case series and experimental studies, with encouraging but still developing results.

The common scientific rationale is the ability of hyperbaric oxygen to modulate the immune response by reducing pathological activation and enhancing regulatory mechanisms.

This immunomodulatory effect, combined with its anti-inflammatory and antioxidant effects, provides the biological basis for its use in the field of autoimmune diseases.

Purpose of Maxillofacial Surgical Indications

The jaw and oral region presents unique biological challenges for healing: bone tissue in direct contact with the oral microbiome, extensive vascularization that may be disrupted following radiotherapy or certain medications, and continuous mechanical stress from chewing.

In this demanding environment, healing and restoration of bone structures require optimal biological conditions, and inadequate oxygenation is often a major limiting factor.

Hyperbaric oxygen chamber therapy has become established in maxillofacial surgery as one of the most reliable complementary interventions for conditions associated with hypoxia in irradiated or vascularly compromised bone.

By restoring oxygenation, it restores the tissue to the biological conditions it needs to heal, integrate implants, or combat infections, always as a complement to surgical and dental care.

Key Characteristics of the Treatment

In the maxillofacial field, hyperbaric oxygen chamber therapy acts on three main levels. First, it directly improves oxygenation of bone tissue by increasing dissolved oxygen in the plasma, allowing it to reach even areas with inadequate blood supply.

It then induces neoangiogenesis through VEGF, which restores the vascular infrastructure of the affected tissue over the long term. Finally, it activates osteoblasts to promote increased bone regeneration and exerts a bactericidal effect against anaerobic pathogens that are often involved in jaw infections.

The synergy of these three effects makes hyperbaric oxygen particularly useful in situations where jaw tissue has diminished biological capacity—for example, following radiotherapy or chronic infection—and requires substantial biological support to meet therapeutic demands.

Scientific Evidence

Maxillofacial surgery is one of the fields with the strongest scientific evidence supporting the use of hyperbaric oxygen. Osteoradionecrosis of the jaw is an approved indication by the UHMS and ECHM, with a high level of supporting evidence based on established randomized studies.

For other indications—such as implants in irradiated jaws, jaw osteomyelitis, and periodontitis—the scientific evidence is steadily increasing.

In all cases, treatment is administered in close collaboration with the maxillofacial surgeon or specialized dentist, as a complement to surgical management and not as a substitute for it.

Brief Description and Purpose

The skin is the largest organ of the human body and the first line of defense against the environment.

Its ability to respond, heal, and renew itself depends to a large extent on adequate local oxygenation: without sufficient oxygen, fibroblasts cannot synthesize collagen, keratinocytes cannot proliferate effectively, and immune mechanisms become impaired.

Within this context, hyperbaric oxygen chamber therapy is particularly relevant for dermatological conditions characterized by chronic inflammation, delayed healing, or tissue damage.

It does not approach the skin superficially; rather, it addresses the underlying biological imbalances that contribute to the pathology. And always as a complementary method, within the framework of dermatological monitoring.

Key Characteristics of the Treatment

In dermatological conditions, hyperbaric oxygen chamber therapy exhibits three primary properties: anti-inflammatory action through the inhibition of inflammatory cytokines; regenerative action through the activation of fibroblasts and keratinocytes, promoting increased collagen synthesis and epithelialization; and antimicrobial action against anaerobic pathogens that thrive in a hypoxic skin environment.

In addition, the neoangiogenesis induced by hyperbaric oxygen improves skin microcirculation over the long term, ensuring that the regenerating tissue has the biological infrastructure needed to remain healthy.

This combination of immediate action and long-term improvement makes the method particularly interesting for chronic or treatment-resistant dermatological conditions.

Scientific Basis

The evidence supporting the use of hyperbaric oxygen in dermatological conditions comes from two directions: studies of healing mechanisms, in which the contribution of oxygenation is well established, and clinical studies in specific conditions such as burns, skin grafts, and chronic dermatological diseases.

For certain indications, such as graft support, the evidence is strong and recognized by the UHMS. For others, such as psoriasis, the evidence is emerging but promising.

In all cases, treatment is administered under dermatological supervision and in a complementary role, enhancing the effectiveness of the primary dermatological treatment and never replacing it.

Brief Description of Neurological Conditions

The nervous system is the tissue most vulnerable to oxygen deprivation: nerve cells do not survive for more than a few minutes under conditions of complete ischemia, while even partial hypoxia, if prolonged, can lead to degeneration and loss of function.

At the same time, the brain and spinal cord have a limited capacity for self-renewal compared with other tissues, making any neurological injury potentially long-lasting.

Hyperbaric oxygen chamber therapy is incorporated into the neurological field as a complementary method with a clear biological rationale: increasing oxygenation in nervous tissue, even in areas with reduced blood flow, may help preserve nerve cells that are on the threshold of viability, slow degenerative processes, and create more favorable conditions for neurological recovery.

Never as a standalone treatment, but always as an adjunct to neurological and rehabilitation care.

Key Characteristics of the Treatment

In the neurological field, hyperbaric oxygen chamber therapy offers properties that are particularly relevant to this category of patients.

First, hyperoxygenation under pressure allows oxygen to diffuse more deeply into brain tissue independently of blood vessel function, reaching areas that conventional circulation cannot adequately supply.

In addition, hyperbaric oxygen reduces cerebral edema—a factor that can aggravate injury in many neurological conditions—activates neurotrophic factors that support neuronal survival, reduces neuroinflammation, and enhances neuroplasticity: the brain's ability to reorganize its neural connections. These properties make it a particularly interesting tool in neurological rehabilitation.

Scientific Research

Research into the use of hyperbaric oxygen in neurological conditions is continually evolving. There is established evidence for certain conditions, such as acute cerebral ischemia and decompression sickness, while for others, such as multiple sclerosis and neurodegenerative diseases, the evidence is promising but continues to be evaluated.

The common thread across all applications is the biological rationale: the nervous system is highly dependent on oxygenation, and any intervention that improves local oxygen availability may, in theory and often in practice, positively influence the course of the disease. Treatment is always administered under neurological supervision and as a complement to conventional therapy.

A Brief Overview of Oncological Complications

Radiotherapy is a cornerstone of modern oncology and has contributed to saving the lives of millions of patients worldwide. However, tissues within the radiation field undergo biological changes that are not limited to the active phase of treatment; on the contrary, they often manifest months or even years later, creating painful and disproportionately serious complications.

Radiation-induced injuries result from the gradual fibrotic degeneration and vascular damage caused by radiation to irradiated tissues. The result is chronic hypoxia, impaired regenerative capacity, and increased susceptibility to infection and necrosis.

Hyperbaric oxygen chamber therapy addresses precisely this underlying pathology: it restores oxygenation to irradiated tissues, reactivates regenerative mechanisms that have become impaired, and significantly improves the patient's quality of life, always as a complementary intervention within the framework of oncological care.

Oncological Complications & Treatment

In oncological complications, hyperbaric oxygen chamber therapy differs in its objective from other applications: here, it does not treat an acute injury but rather chronic, established pathology caused by cancer treatment.

Hypoxia in irradiated tissues is not temporary; it is structural, resulting from the permanent vascular damage caused by radiation. Without intervention, it may worsen over time.

Repeated exposure to high concentrations of oxygen helps “break” this vicious cycle: it restores oxygenation in chronically hypoxic tissues, stimulates neoangiogenesis to create new blood vessels in place of damaged ones, reduces chronic inflammation, and reactivates cells that have become biologically inactive.

The result is improved function of irradiated tissues and a reduction in symptoms that negatively affect quality of life.

Scientific Studies

Radiation-induced complications are among the most extensively documented indications for hyperbaric oxygen in the international scientific literature. The UHMS and ECHM classify conditions such as osteoradionecrosis, radiation-induced cystitis, radiation-induced proctitis/colitis, and soft-tissue radiation injuries as approved indications, with a high level of clinical evidence.

Randomized clinical studies have demonstrated significant improvements in healing parameters, reductions in pain, and improvements in quality of life among patients who received hyperbaric oxygen for radiation-induced complications.

The scientific evidence consistently emphasizes the importance of early intervention, before tissue damage progresses to irreversible necrosis, as well as individualized treatment under oncological supervision.

Brief Description: Orthopedic Conditions

Orthopedic conditions and musculoskeletal injuries are among the most common causes of pain, disability, and reduced quality of life in the adult population.

Whether they involve chronic conditions such as osteonecrosis or osteomyelitis, or conditions that arise following surgery, the recovery process often requires a multifaceted approach.

Hyperbaric Oxygen Therapy is incorporated into this framework as an evidence-based complementary method that works alongside orthopedic treatment—whether pharmaceutical, surgical, or physiotherapeutic—supporting tissue regeneration, reducing inflammation, and accelerating healing.

Its purpose is not to replace established treatments, but to enhance their effectiveness.

Key Characteristics of the Treatment

Hyperbaric oxygen in orthopedic conditions is based on the principle of tissue hyperoxygenation. Under increased atmospheric pressure, the patient breathes pure oxygen, which dissolves in greater quantities in the blood plasma and reaches tissues that, due to injury or inflammation, have reduced blood flow.

The main characteristics of the treatment in the orthopedic field include: promoting neoangiogenesis in ischemic areas, stimulating osteoblasts to support bone regeneration, reducing post-traumatic edema, and exerting antimicrobial effects in cases of chronic infection such as osteomyelitis. At the same time, it contributes to pain reduction by suppressing the inflammatory response.

Scientific Basis

The use of hyperbaric oxygen in orthopedic rehabilitation is supported by a growing number of clinical studies and guidelines from international organizations such as the Undersea and Hyperbaric Medical Society (UHMS).

Research has demonstrated its beneficial role in conditions such as osteonecrosis, chronic bone infections, and delayed fracture healing. Studies in patients with osteomyelitis have shown significant reductions in infection and improved tissue healing when hyperbaric oxygen therapy was incorporated as a complementary component of the treatment protocol.

It is important to emphasize that its effects are maximized when it is applied in combination with appropriate orthopedic or physiotherapeutic treatment, under the guidance of a specialized medical team.

Types of Conditions

The following pages provide a detailed analysis of the orthopedic conditions for which hyperbaric oxygen may serve as reliable complementary support.

Brief Description and Purpose

The genitourinary system contains a particularly sensitive anatomical and functional infrastructure: mucous membranes with high metabolic demands, vascular networks that are directly affected by systemic diseases, and tissues that, in cases of radiotherapy or chronic inflammation, undergo permanent biological changes that are difficult to reverse through conventional means.

Hyperbaric oxygen chamber therapy is incorporated into urology as a complementary intervention with a clear biological rationale: by restoring oxygenation in tissues with vascular insufficiency, reducing chronic inflammation, and activating regenerative mechanisms, it helps urological tissue restore functions that have been disrupted by disease, radiation, or surgery. Always alongside conventional urological care, never as a substitute for it.

Key Characteristics of the Treatment

In the urological field, hyperbaric oxygen chamber therapy utilizes four key properties. First, it directly improves oxygenation of tissues with reduced vascular supply, whether due to radiation injury or chronic inflammation.

It then induces neoangiogenesis through VEGF for long-term restoration of the vascular infrastructure. At the same time, it exerts a strong anti-inflammatory effect that reduces chronic inflammation of mucous membranes. Finally, it activates healing mechanisms in tissues that have become biologically inactive due to ischemia.

The synergy of these four mechanisms makes the method particularly suitable for urological conditions characterized by chronicity and resistance to conventional treatments.

Scientific Basis

In the urological field, the strongest scientific evidence concerns radiation-induced hemorrhagic cystitis, an approved indication by the UHMS, with response rates of 70–90% reported in the literature.

For other urological applications, such as chronic prostatitis, male infertility, and postoperative complications, the scientific evidence is steadily growing, with emerging but promising clinical data.

The common scientific rationale is improved tissue oxygenation: in each urological condition within this category, ischemia or hypoxia is a critical pathophysiological factor, and addressing it has demonstrated clinical benefits.

Ophthalmological Conditions

The retina is one of the most metabolically demanding tissues in the human body: its photoreceptor cells consume oxygen at rates comparable to those of the cerebral cortex.

This extremely high energy demand makes it highly sensitive to any disruption in blood flow; even a few minutes of ischemia can be sufficient to cause irreversible damage.

Hyperbaric oxygen chamber therapy is of particular importance in vascular diseases of the eye precisely because of this characteristic: by providing amounts of oxygen that reach the retina independently of obstructed or dysfunctional blood vessels, it gives photoreceptors and ganglion cells a critical second chance for survival.

Always as an emergency adjunctive intervention, alongside time-critical ophthalmological management.

Key Characteristics of the Treatment

In vascular diseases of the eye, hyperbaric oxygen chamber therapy utilizes a unique physiological mechanism: under hyperbaric conditions, the amount of oxygen dissolved in the plasma increases so dramatically that it can supply the retina independently of the condition of the retinal arteries and veins.

The vitreous humor and the aqueous layers surrounding the retina function as alternative pathways for oxygen diffusion.

At the same time, hyperbaric oxygen induces vasoconstriction in normal blood vessels, a phenomenon that reduces intraocular edema and may paradoxically improve blood flow to adjacent ischemic areas.

In addition, it activates anti-apoptotic mechanisms that delay neuronal death and provide time for restoration of the primary vascular injury.

Scientific Basis

The use of hyperbaric oxygen in vascular diseases of the eye is based on a body of clinical studies, case series, and experimental data documenting the preservation of visual function in acute ischemic conditions.

The UHMS recognizes central retinal artery occlusion as an indication, emphasizing that the therapeutic window is extremely narrow and that effectiveness is directly associated with how quickly treatment is initiated.

In all applications, the therapy is incorporated as an emergency adjunctive intervention; it does not replace ophthalmological evaluation or specialized interventional techniques, but provides biological support to ischemic tissue while these interventions are being performed or awaited.

Brief Description and Purpose

The inner ear is one of the most sensitive and finely organized sensory mechanisms in the human body. The hair cells of the cochlea, the auditory sensory receptors, and the blood vessels that supply them respond immediately to any disruption in blood flow or oxygenation, and because they lack collateral circulation, even transient ischemia can leave permanent effects.

Hyperbaric oxygen chamber therapy is incorporated into the otological field as one of the most well-documented applications of the method. The rationale is simple and scientifically sound: by restoring oxygenation to the cochlea and auditory nerve, the affected tissue is given the biological capacity to recover, provided that treatment is initiated promptly.

Always in an adjunctive role and under otological supervision.

Key Characteristics of the Treatment

In otolaryngological conditions, hyperbaric oxygen chamber therapy utilizes a fundamental physiological mechanism: the inner ear is supplied by a single end artery, the cochlear artery, without collateral vessels capable of compensating for any obstruction or ischemia.

This means that any disruption in blood flow directly and inevitably affects the oxygenation of cochlear tissue.

Hyperoxygenation under increased pressure allows oxygen to reach the cochlea through dissolution in the aqueous compartments of the inner ear, independently of blood flow.

At the same time, endolymphatic pressure is reduced, the inflammatory response associated with many otological conditions is inhibited, and regenerative mechanisms are activated in cochlear hair cells that are in a state of functional inhibition.

Scientific Basis

Sudden sensorineural hearing loss is the most well-documented otological indication for the use of hyperbaric oxygen. The UHMS and ECHM classify it as an approved indication, emphasizing that effectiveness is directly related to the speed of initiation; early intervention, within the first few days, produces significantly better outcomes than delayed treatment.

For tinnitus and other otological conditions with an ischemic basis, the scientific evidence is still developing but encouraging.

The common thread across all applications is the same pathophysiological mechanism: restoring oxygenation to a tissue that depends absolutely on a continuous and adequate supply of oxygen to function.

Pathological Conditions and Hyperbaric Oxygen

There are pathological conditions that resist conventional therapeutic approaches not because they are incurable, but because conventional medicine has not yet found an effective way to address the deeper pathophysiological mechanisms that drive them.

Conditions such as Crohn’s disease, fibromyalgia, and chronic fatigue develop against a biological background characterized by chronic inflammation, oxidative stress, mitochondrial dysfunction, and, in many cases, inadequate tissue oxygenation.

Hyperbaric oxygen chamber therapy is incorporated into this field as a biologically targeted adjunctive intervention that acts on these common mechanisms: it improves cellular oxygenation, reduces systemic inflammation, enhances mitochondrial function, and reduces oxidative stress.

It does not treat the disease as an entity but improves the biological conditions under which the body is called upon to address it, while also enhancing the effectiveness of the primary treatment.

Key Characteristics of Pathological Conditions

The common principle of action of hyperbaric oxygen across all pathological conditions in this category is addressing the biological imbalance that characterizes each condition.

For Crohn’s disease, this means improving the oxygenation of inflamed mucosa and suppressing inflammatory cytokines. For chronic fatigue, it means restoring mitochondrial energy production. For fibromyalgia, it means improving muscle oxygenation and addressing neuroinflammation. For inflammatory syndromes, it means systemic anti-inflammatory activity through biological rather than pharmacological mechanisms.

The absence of significant side effects and the non-invasive nature of the treatment make it particularly suitable for patients who are already subject to a substantial medication burden or who are seeking alternative supportive options as part of their treatment.

Scientific Evidence

The scientific evidence for the use of hyperbaric oxygen in pathological conditions is at different stages of maturity depending on the condition. For Crohn’s disease, there are clinical studies with encouraging results, particularly in refractory or inflammatory flares.

For fibromyalgia and chronic fatigue, the data are emerging but promising, with growing research interest. In all cases, the treatment is applied in an adjunctive role and under the supervision of the treating physician or specialist.

The common scientific basis is the documented ability of hyperbaric oxygen to reduce systemic inflammatory markers (CRP, IL-6, TNF-α), improve mitochondrial function, and enhance antioxidant mechanisms—factors that are pathophysiologically involved in all of these conditions.